Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
94.06
+1.58 (1.71%)
At close: Apr 28, 2026, 4:00 PM EDT
94.00
-0.06 (-0.06%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Mirum Pharmaceuticals Employees
As of December 31, 2025, Mirum Pharmaceuticals had 372 total employees, including 369 full-time and 3 part-time employees. The number of employees increased by 50 or 15.53% compared to the previous year.
Employees
372
Change (1Y)
50
Growth (1Y)
15.53%
Revenue / Employee
$1,401,376
Profits / Employee
-$62,804
Market Cap
5.74B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| Apellis Pharmaceuticals | 739 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Immunovant | 362 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
MIRM News
- 1 day ago - Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus - Business Wire
- 15 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 19 days ago - Egetis Appoints Tiago Nunes as Chief Medical Officer - Accesswire
- 6 weeks ago - Mirum Pharmaceuticals Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Additional Rare Cholestatic Liver Diseases - Business Wire
- 6 weeks ago - Mirum Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Mirum Pharmaceuticals Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus - Business Wire
- 2 months ago - Mirum Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts